Bayern Innovativ conceives and organises as coordinator of the international Network Life Science the 4th Cooperation Forum “Drug Development” in close cooperation with the Enterprise Europe Network and the University Würzburg.
Already more than 160 participants from Germany, France, Belgium, Italy and the US are registered, from companies and research organisations such as Aeterna Zentaris, Amgen, Amptec, AURIGON Life Science, Biomet, Boehringer Ingelheim, Cardiac Research, Daiichi Sankyo, Ditabis, Focus Clinical Drug Development, Fluoron, Fraunhofer-Gesellschaft, GE Healthcare, Genelux, Intana Bioscience, Invitrogen, Morphosys, Oncolead, PROvendis, Ratiopharm, Rentschler Biotechnologie, Roche, SGS Lifescience, Thermo Fisher, TransMIT Biotronik, Olympus
Genelux, Wilex, Max-Planck-Innovation as well as the Universities Hamburg, Regensburg, Erlangen and Würzburg.
Attendee: Dr. Christian Haug (Managing Director, Bicoll GmbH)
